Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
In Sign-Off Of Two Orphan Drugs, ODAC Leaves Efficacy Interpretation To Docs
This article is from
The Cancer Letter
archive.
Vol. 24 No. 45 | November 27, 1998
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
1st Cancer Patients Treated With Gene Therapy At NIH
February 1, 1991
TCL Archive
Americans Shouldn’t Take NIH for Granted, Healy Tells NCAB
May 24, 1991
TCL Archive
NIH Clinical Center Offers Sabbatical In Clinical Research Management
October 1, 2010
TCL Archive
Youth Smoking Linked To Exposure In Movies
December 30, 2005
TCL Archive
Marie Lombardi NCAB Member, Dies; HHS Holding Up Board Appointments
April 23, 1982
TCL Archive
GAO Report Finds Increase in Self-Referred Pathology Services
August 9, 2013